Working... Menu
Trial record 5 of 30 for:    IGFBP2

Vaccine Therapy in Treating Patients With Stage III-IV or Recurrent Ovarian Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01322802
Recruitment Status : Active, not recruiting
First Posted : March 25, 2011
Last Update Posted : April 4, 2019
National Cancer Institute (NCI)
Information provided by (Responsible Party):
University of Washington

No Study Results Posted on for this Study
  Recruitment Status : Active, not recruiting
  Actual Primary Completion Date : January 9, 2015
  Study Completion Date : No date given